Efficacy and safety of 2-hour urokinase regime in acute pulmonary embolism: a randomized controlled trial
<p>Abstract</p> <p>Backgrounds</p> <p>Urokinase (UK) 2 200 U/kg·h for 12 hours infusion(UK-12 h)is an ACCP recommended regimen in treating acute pulmonary embolism (PE). It is unclear whether this dose and time can be reduced further. We compared the efficacy and safety...
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2009-12-01
|
| Series: | Respiratory Research |
| Online Access: | http://respiratory-research.com/content/10/1/128 |